Evidence map›Paper›PMID 37637463›Full record

ArticleFrontiers in cellular and infection microbiology2023

Genetic analysis of resistance and virulence characteristics of clinical multidrug-resistant

Ying Li, Ming Yin, Chengju Fang, Yu Fu, Xiaoyi Dai, Wei Zeng, Luhua Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 18 citations in OpenAlex.

  1. Pangenome analysis ofAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular characterization of multidrug-resistantIranian journal of microbiology · 2025
    Article
  11. Microorganisms · 2025
    Article
  12. Outbreak Caused by VIM-1- and VIM-4-PositivePathogens (Basel, Switzerland) · 2025
    Article
  13. Outbreak of NDM-5-ProducingAntibiotics (Basel, Switzerland) · 2025
    Article
  14. First Report of CTX-M-32 and CTX-M-101 inAntibiotics (Basel, Switzerland) · 2025
    Article
  15. Clonal Dissemination of NDM-ProducingPathogens (Basel, Switzerland) · 2025
    Article
  16. Review
  17. Some Virulence-Associated Genes ofInternational journal of microbiology · 2025
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ying LiThe School of Basic Medical Science and Public Center of Experimental Technology, Southwest Medical University, Luzhou, Sichuan, China.
Ming YinThe School of Basic Medical Science and Public Center of Experimental Technology, Southwest Medical University, Luzhou, Sichuan, China.
Chengju FangThe School of Basic Medical Science and Public Center of Experimental Technology, Southwest Medical University, Luzhou, Sichuan, China.
Yu FuThe School of Basic Medical Science and Public Center of Experimental Technology, Southwest Medical University, Luzhou, Sichuan, China.
Xiaoyi DaiThe School of Basic Medical Science and Public Center of Experimental Technology, Southwest Medical University, Luzhou, Sichuan, China.
Wei ZengDepartment of Clinical Laboratory, The Hejiang People's hospital, Luzhou, Sichuan, China.
Luhua ZhangThe School of Basic Medical Science and Public Center of Experimental Technology, Southwest Medical University, Luzhou, Sichuan, China.
Southwest Medical University · CNQujiang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods and results: Antibiotic susceptibility testing revealed fourteen MDR strains, which showed high resistance to most β-lactams and trimethoprim/sulfamethoxazole, and a lesser extent to quinolones. All the MDR strains were sensitive to carbapenems (except imipenem), ceftazidime, and amikacin, and most of them were also sensitive to aminoglycosides. The obtained MDR isolates were sequenced using an Illumina HiSeq. The core genome-based phylogenetic tree reveals the high genetic diversity of these MDR Conclusion: In conclusion, the prevalence of MDR

Indexed as

Anti-Bacterial AgentsProteus mirabilisAmikacinCaspase 1PhylogenyVirulenceAmikacinAnti-Bacterial AgentsCaspase 1blaCTX-M-65ICEPmGRI1Proteus mirabilisvirulence

Identifiers

PMID37637463
PMCPMC10457174
OpenAlexW4385758259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.